Navigation Links
TPI Ships Macrolide API Samples for International Sales Standard Testing
Date:7/22/2011

CHENGDU, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the research, development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients (API) today announced that the Company has shipped the first batch of Azithromycin API sample to RELATIONS International Ltd. for Bangladesh export standard test.  

This is the first step for the development of macrolide international export business for TPI following the signing of the sales and marketing agreement with RELATIONS International Ltd., a Bangladesh corporation that specializes in API product sales in the People's Republic of Bangladesh, in June this year.

Jiangchuan Macrolide facility (JCM) currently has an active production license for manufacturing Azithromycin API (H10970072). Additional information regarding JCM can be found at www.sfda.gov.cn (Chinese version).  

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and active pharmaceutical ingredients (API). TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

About RELATIONS International Ltd.

RELATIONS International Ltd. (RELATIONS), founded in 1978, incorporated in the People's Republic of Bangladesh, is located at Motijheel Commercial Area, Dhaka-1000, Bangladesh. It specializes in the sales of APIs and other medical/pharmaceutical products in Bangladesh. RELATIONS client base includes Sandoz - Austria, Spain, Italy, Germany & India, Sifavitor, ABC Farmaceutici, Solmag, Recordati, SIMS, Farchemia and Archimia etc of Italy, Kirsch, CF Budenheim, Peter-Greven of Germany, Viscose Closures of UK, Fuji Kasei, Kyowa Hakko and Kaneka of Japan. RELATIONS also established a number of business relations with Chinese manufactures including TPI.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharma.com, or email ir@tianyinpharma.com      

Tel:     +86-28-8551-6696 (Chengdu, China)
           +86-134-3655-0011 (China)
Address:  
Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza      
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
2. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
3. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
4. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
5. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
6. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
7. AMD LASERS Announces Partnerships With Three Industry-Leading Companies
8. PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
9. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
10. Codexis Expands Pharmaceutical Manufacturing Partnerships
11. ExpertRECALL Awards First Scholarships for Product-Safety Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 West Pharmaceutical Services, ... solutions for injectable drug administration, today announced that it ... opens on Thursday, October 26, 2017, and will follow ... business expectations at 9:00 a.m. Eastern Time. To participate ... (International). The conference ID is 94093362. ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):